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INTRODUCTION
In mammals, homeostasis of inorganic phos-
phate (P) in the blood is mainly maintained by the
regulation of renal P reabsorption (1). Type IIa
sodium-dependent P transporter (NaPi-IIa) is a
multi-trans membrane protein and plays a critical
role in the rate-limiting step of renal P reabsorp-
tion (2). The P transport activity in the proximal
tubule is dependent on the amount of NaPi-IIa in
the apical plasma membrane (2). Generally, the
amount of trans-membrane protein in apical plasma
membrane is controlled by the balance of exocy-
totic/endocytotic protein transport rate and reten-
tion time in the plasma membrane. Most of the P
regulating factors, such as parathyroid hormone
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(PTH) and fibroblast growth factor 23 (FGF23),
are thought to affect the regulation of NaPi-IIa ac-
tivity (3, 4). However, the detailed mechanisms have
not yet been clarified.
Studies in the past decade have elucidated the
mechanism for the apical localization of NaPi-IIa
(5). NaPi-IIa can form a macromolecular complex
on the apical plasma membrane via NHERFs (so-
dium - proton exchanger related factors), ERM
(ezrin/radixin/moesin) family proteins, and actin
cytoskeleton (5). NaPi-IIa can bind to the first PDZ
domain of NHERF-1 via the TRL-motif in the C-
terminus (6). The C-terminal region of NHERF-1
can bind to the N-terminal FERM domain of ERM
proteins (7). Then, the C-terminal domain of ERM
proteins can bind to the actin cytoskeleton (8). Mac-
romolecular complexes such as this are important
in the determination of the apical localization of
NaPi-IIa (5). In addition, NaPi-IIa can be localized
in specialized membrane microstructures, such as
clathrin-coated pits (9), and/or low-density mem-
brane microdomains (LDM), including lipid rafts/
caveolae in the apical plasma membrane (10-12).
Ezrin also plays an important role in the localization
of NaPi-IIa in the LDM (10).
NHERF-1 plays an important role in the regulation
of apical localization of NaPi-IIa. PTH-stimulated
phosphorylation of serine 77 of NHERF-1 through
protein kinase C (PKC) results in the dissociation
of the interaction between NaPi-IIa and NHERF-1
(13, 14). The PTH-mediated down-regulation of
NaPi-IIa was disrupted in NHERF-1 deficient mice
(15), and apical localization of NaPi-IIa can remain
intact, even in NHERF-1 deficient mice (15). In con-
trast, ezrin, which is another important molecule
for the apical localization of NaPi-IIa, regulates the
apical localization of NaPi-IIa in the membrane mi-
crodomains and NaPi-IIa activity. PTH may also
phosphorylate ezrin by protein kinase A (PKA) as
well as protein kinase C (PKC), affecting the for-
mation of the NaPi-IIa complex in the apical plasma
membrane (10). Overexpression of dominant nega-
tive ezrin (N-terminal half of ezrin) inhibits the api-
cal localization of NaPi-IIa and P transport activity
in the renal proximal tubular cells (10, 16). These
results suggest that modification of the N-terminal
half of ezrin by phosphorylation is mechanistically
important. In this study, we investigated the role
of the phosphorylation of ezrin in apical membrane
localization of NaPi-IIa in renal proximal tubular
cells.
MATERIALS AND METHODS
Expression and purification of recombinant human
ezrin in Escherichia coli
Complementary DNA (cDNA) fragments of hu-
man ezrin were amplified by polymerase chain re-
action (PCR) using a high fidelity PCR system
(Roche Japan, Tokyo, Japan) with the specific oli-
gonucleotide primers listed in Table 1. The PCR-
amplified cDNA fragment corresponding to the N-
terminal region of human ezrin (amino acids, aa, 2-
348) was inserted into the pET30a vector (Merck
Chemicals Japan, Tokyo, Japan). The constructed
expression vector was transformed into single step
(KRX) competent cells (Promega, Madison, WI).
The 6xHis-tagged recombinant protein produced by
E. coli in LB medium containing 20% rhamnose at
15-25overnight was purified with TALON Metal
Affinity Resins according to the manufacturer’s
Table. 1 Oligonucleotide primer sequences for amplifying human ezrin cDNA and site -directed mutagenesis
Full length ezrin Sense : 5’ -GCT CTA GAC CGA AAA TGC CGA AAC CAA TC-3’
Antisense : 5’ -TCG GGC CCA AGC TTC AGG GCC TCG AAC TC-3’
N-terminal half ezrin Sense : 5’ -CTT GAC GCG TTG ATA TCA ACT AGT CCG AAA CCA ATC AAT-3’
Antisense : 5’ -GAC ATT GAT TGG TTT CGG ACT TGA TAT CAA CGC GTC AAG-3’
For T567D Sense : 5’ -CCG GGA CAA GTA CAA GGA CCT GCG GCA GAT CCG GC-3’
Antisense : 5’ -GCC GGA TCT GCC GCA GGT CCT TGT ACT TGT CCC GG-3’
For S149D Sense : 5’ -CTG GGT ACC TCA GCG ATG AGC GGC TGA TCC C-3’
Antisense : 5’ -GGG ATC AGC CGC TCA TCG CTG AGG TAC CCA G-3’
For S249D Sense : 5’ -GTC AAA TCA GGA ACA TCG ATT TCA ATG ACA AAA AGT T-3’
Antisense : 5’ -AAC TTT TTG TCA TTG AAA TCG ATG TTC CTG ATT TCA C-3’
Bold letter shows substituted nucleotide. Underline shows codon corresponded to substituted amino acid.
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instructions (GE Healthcare Japan, Tokyo, Japan).
SDS-polyacryl amide gel electrophoresis and western
blot analysis
Proteins were separated by sodium dodecyl sul-
fate (SDS)-polyacrylamide gel electrophoresis (SDS-
PAGE) and were subjected to either Coomassie
Brilliant Blue (CBB) staining or western blot analy-
sis. For western blot analysis, the separated pro-
teins were transferred to a polyvinylidine difluoride
(PVDF) membrane (Millipore Japan, Tokyo, Japan),
and blotted for NaPi-IIa. Immunoreactive bands
were visualized using enhanced chemiluminescence
(ECL Plus, GE Healthcare Japan) and were ana-
lyzed with an LAS-3000mini lumino-image analyzer
(Fujifilm, Tokyo, Japan).
In vitro phosphorylation assay
In vitro phosphorylation with PKA was performed
using the purified recombinant N-terminal half of
ezrin, or synthetic peptides containing putative phos-
phorylation sites S149 (aa, 145-154, GYLSSERLIP)
and S249 (aa, 244-253, EIRNISFNDK), and their
alanine-substituted mutants S149A (GYLSAERLIP)
and S249A (EIRNIAFNDK). Each protein or pep-
tides was incubated in reaction buffer for the PKA
assay (50 mM Tris, 10 mM MgCl2, 1 mM ATP, pH
7.5), containing [γ - 32P]ATP, (30 MBq/ml, MP Bio-
medicals Japan, Tokyo, Japan), and PKA catalytic
subunit (New England Bio Labs, Ipswich, MA) at
30for 30 min. Using recombinant protein, the re-
action mixture was separated by SDS-PAGE and
radiolabeled proteins were detected by an imaging
analyzer (BAS -3000, Fuji Film). Using synthetic
peptide, the reaction mixture was absorbed onto a
P81 phosphocellulose filter (Whatman Japan, Tokyo,
Japan) and was washed out and counted using a
liquid scintillation counter.
Cell culture, expression vector construction for
mammalian cells, and transfection
Opossum kidney cells (OK-P cells) were obtained
from kidney tissues provided by Dr. J. Cole. OK-P
cells and COS-7 cells were maintained in plastic cul-
ture dishes in Dulbecco’s modified Eagle’s medium
(DMEM, Life Technologies Japan, Tokyo, Japan)
containing 25 mmol/L HEPES, 4500 mg/mL glu-
cose, 1 mmol/L sodium pyruvate, 50 μg/mL peni-
cillin, 50 IU/mL streptomycin, and 10% (vol/vol)
fetal bovine serum (FBS), all from Sigma-Aldrich
Japan (Tokyo, Japan) at 37, in a humidified atmos-
phere of 5% CO2. GFP-human NaPi-IIa expression
vector was used as previously reported (17). Each
cDNA of the full-length of ezrin and N-terminal half
of ezrin (dominant negative ezrin ; Ezrin-DN) was
subcloned into pDsRed2 plasmid vector (Takara Bio
Inc, Otsu, Japan) and expressed in OK-P cells as
fusion protein with DsRed. Substitution of aspartic
acid for serine or threonine was performed by site-
directed mutagenesis using QuikChange site-direct
mutagenesis kit (Agilent Technologies Japan, Tokyo,
Japan) with the specific oligonucleotide primers
listed in Table 1. Transfection was carried out using
Lipofectamine 2000 reagent (Life Technologies Ja-
pan) as previously described (10).
P uptake assay
P uptake assay was measured in OK-P cells
grown to confluency in 24-well plastic plates as pre-
viously described (10). Transport rate was expressed
as nmol P per mg protein per minute.
Fluorescence microscopy analysis
OK-P cells transfected with expression vectors
for GFP-human NaPi-IIa and DsRed-dominant
negative ezrin with or without S249D mutation were
grown on cover slips. Then, the cells were fixed
with 3% (wt/vol) paraformaldehyde for 30 min on
ice. The cover slips were mounted on glass slides
and analyzed under a Leica Confocal Microscope
(TCS-LS, Leica Microsystems GmbH, Mannheim,
Germany) in the sequential mode. The x and y
plane images (512 x 512 pixels per image) were
obtained in the x, y, and z scan mode, and 18 z
section images were taken per region of interest.
The top 1 to 4 section images were projected onto
one xy image.
Cell fractionation
OK-P cells were transfected with expression vec-
tors for GFP-NaPi-IIa and constitutive active ezrin
(Ezrin-CA ; full-length ezrin with phosphomimetic
mutation at T567D), or constitutive active ezrin with
the S249D mutation (Ezrin-CA/S249D). Mutagene-
sis of the expression vectors was performed as de-
scribed above. The non-detergent method (18) for
isolating LDM from OK-P cells was employed as
previously described (10). Sonicated plasma mem-
branes were subjected to OptiPrep gradient cen-
trifugation twice. The opaque band just above the
5% interface after the second OptiPrep gradient
centrifugation was collected and designated as the
LDM fraction.
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Mammalian two-hybrid analysis
The mammalian two -hybrid assay system
(Promega) was employed to analyze the effect of
amino acid substitution of FERM-domain of human
ezrin on the interaction with C-terminal NHERF-1.
Rat C-terminal NHERF-1 cDNA (corresponding to
aa 272-356) was inserted into a bait pBIND vector
containing the GAL4 DNA binding domain (pBIND-
NHERF-1). The N-terminal half of human ezrin
cDNA (corresponding to aa 2-348) was inserted into
a prey pAct vector containing the VP16 transcrip-
tional activation region (pAct-ezrin). Site-directed
mutagenesis of pAct-ezrin S149D and pAct-ezrin
S249D was generated from the pAct-ezrin, as pre-
viously described above. Vectors for bait and prey,
luciferase reporter vector (pG5luc), and control vec-
tor (pCMVβ) for expression of β -galactosidase were
cotransfected into COS-7 cells with the Lipofec-
tamin 2000 reagent. After 24-h transfection, cells
were lysed and measured for both luciferase and β -
galactosidase activity. Interaction was evaluated by
luciferase activity and the data were normalized by
β -galactosidase activity.
Determination of protein concentration
Protein concentration was determined using the
Bio-Rad Bradford assay (Bio-Rad Japan, Tokyo,
Japan) with bovine serum albumin as a standard.
Statistical analysis
All values from more than triplicate experiments
are expressed as meanSE. Data from less than
duplicate data are expressed as mean. The signifi-
cance of differences was assessed between groups
using analysis of variance (ANOVA) with post-hoc
analyses by Fischer’s protected least significant dif-
ference test, when the available sample size was
more than 3. Differences were considered signifi-
cant at p0.05. Statistical analysis was performed by
StatView (version 5.0-J for Windows, SAS Institute,
Inc., Cary, NC).
RESULTS AND DISCUSSION
Investigation of ezrin of phosphorylation site by PKA
The N-terminal half of ezrin contains a three-re-
peated structure called “FERM domain”. In particu-
lar, the third FERM domain (FERM subdomain-
C ; aa 200-292) is capable of binding to NHERF-1
(19, 20). Therefore, we hypothesized that this region
could interact with the components of the NaPi-
IIa macromolecular complex, such as NHERF-1,
and phosphorylation of this domain may regulate
the interaction between ezrin and other components.
Our previous study suggested that ezrin is phos-
phorylated by PKA or PKC in vivo and has several
candidate phosphorylation sites (T11, S249, and
T332 for PKA, T11, T25, T98, T148, and S149 for
PKC) in the N-terminal region (10) ; however, of
these candidates, only FERM subdomain-C contains
S249. Therefore, we focused on S249 as a candidate
phosphorylation site. First, we investigated whether
PKA can phosphorylate S249 of ezrin in vitro . As
shown in Fig. 1A, PKA phosphorylated the wild-
type recombinant N-terminal half of ezrin. In addi-
tion, we confirmed the phosphorylation of S249 by
in vitro phosphorylation assay using synthetic pep-
tides. As shown in Fig. 1B, PKA phosphorylated
the wild-type peptide but not the mutant peptide
Fig. 1 Ezrin can be phosphorylated by PKA in vitro . (A) Puri-
fied recombinant His- tagged N-terminal half of human ezrin was
purified and confirmed by SDS-PAGE with CBB staining (left).
The purified protein was incubated in the presence (+) or absence
(-) of PKA with [γ - 32P] ATP for 30 min at 30. Reaction prod-
ucts were separated by SDS-PAGE and visualized by autora-
diography. (B) In vitro phosphorylation analysis of putative phos-
phorylation site of ezrin. Each peptide (S149, S149A, S249, and
S249A) was phosphorylated in the presence (+) or absence (-)
of PKA with [γ - 32P] ATP for 30 min at 30. Radiolabelled activity
was measured using a liquid scintillation counter. Data are mean
of duplicate experiments. Representative data from two independ-
ent duplicate experiments are shown.
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S249A. Furthermore, the negative control peptide,
S149, and S149A were also not phosphorylated.
These results suggest that the ezrin S249 can be
phosphorylated by PKA.
Effect of phosphorylation of S249 of ezrin on P
transport activity and the localization of NaPi-IIa
using phosphomimetic mutants
To investigate the role of phosphorylation of ezrin
S249 on the apical localization of NaPi-IIa, we ex-
amined the effects of the phosphomimetic ezrin
S249 mutant (S249D) on the P transport activity and
apical localization of NaPi-IIa in OK-P cells. As pre-
viously reported, the N-terminal half of ezrin has
dominant negative effect on the ezrin function that
is essential for the transport activity of NaPi-IIa in
OK-P cells (10). Therefore, we tested whether phos-
phomimetic mutation S249D can inhibit the domi-
nant negative effect. As shown in Fig. 2, the ex-
pression of the phosphomimetic S249D mutant of
Ezrin-DN (Ezrin-DN/S249D) did not decrease the
P transport activity, while the Ezrin-DN diminished
the P transport activity.
Next, we investigated the effect of the phosphomi-
metic mutation of Ezrin-DN on the subcellular lo-
calization of NaPi-IIa in OK-P cells. Expression of
Ezrin-DN inhibited the localization of GFP-fused
NaPi-IIa on the apical surface in OK-P cells (Fig.
3A). On the other hand, expression of Ezrin-DN/
S249D did not inhibit the localization of NaPi-IIa
(Fig. 3A). In addition, we also investigated the effect
of phosphomimetic mutation S249D in Ezrin-CA
(with T567D mutation) on the localization of NaPi-
IIa in the LDM. Expression of Ezrin-CA enhanced
the amount of NaPi-IIa in the LDM as reported by
Mahon (16) (Fig. 3B). However, Ezrin-CA/S249D
did not enhance the localization of NaPi-IIa in the
LDM fraction (Fig. 3B).
These data suggest that ezrin plays an important
role in the apical localization of NaPi-IIa in renal
Fig. 2 Effects of phosphomimetic mutants of dominant-nega-
tive ezrin on P transport activity in OK-P cells. OK-P cells were
transfected with plasmid vectors expressing GFP-human NaPi-
IIa and expressing Ezrin-DN, its phosphomimetic mutant (Ezrin-
DN/S249D) or mock vector (pDsRed2 ; mock) with DsRed. P
transport activity was expressed as nmol/min/mg protein. Values
are meanSE (n=4). *P0.05 vs. mock.
Fig. 3 Effects of phosphomimetic mutants of dominant nega-
tive ezrin on NaPi-IIa localization in OK-P cells. (A) Fluores-
cence microscopy analysis. OK-P cells were transfected with
plasmid vectors expressing GFP-human NaPi-IIa and express-
ing Ezrin-DN, its phosphomimetic mutant (Ezrin-DN/S249D)
or mock vector (pDsRed2 ; mock) with DsRed. The transfected
cells were transferred onto coverslips, fixed and mounted on
glass slides. Images were taken by confocal laser-scanning mi-
croscopy. The top 1-4 z section images (apical surface images)
were projected onto one x-y plane image as shown above. Rep-
resentative data from 3 to 5 independent experiments are shown.
(B) Cell fractionation analysis. OK-P cells were transfected with
plasmid vectors expressing GFP-human NaPi-IIa and expressing
Ezrin-CA (with T567D mutation) or Ezrin-CA/S249D. Fraction-
ated LDM were subjected to western blot analysis with anti -
NaPi -IIa antibody and anti -caveolin antibody for internal control.
Representative data from 2 independent experiments are shown.
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proximal tubular cells and that phosphorylation of
S249 can inhibit the apical localization of NaPi-IIa.
We considered that Ezrin-DN can bind to NHERF-
1 but cannot tether the NaPi-IIa/NHERF-1 complex
to cytoskeletal actin, resulting in the decrement of
the apical amount of NaPi-IIa. Since the S249D mu-
tant of Ezrin-DN cannot bind to both NHERF-1 and
actin, the dominant negative effect was suppressed.
On the other hand, Ezrin-CA/S249D can bind to
actin but not to NHERF-1 ; therefore, the mutant
inhibited the increment of NaPi-IIa in the LDM
fraction. To confirm our interpretation, we exam-
ined the effect of phosphorylation of ezrin on the
interactions with binding partners, NHERF-1.
Effect of phosphorylation of ezrin on interaction
between ezrin and NHERF-1
Ezrin is a linker protein between NHERF-1 and
cytoskeletal actin in the NaPi-IIa macromolecular
complex. To investigate the role of phosphorylation
of ezrin S249 in the binding to NHERF-1, we ex-
amined whether the phosphomimetic mutant of
ezrin can inhibit the interaction between NHERF-1
by mammalian two-hybrid assay. Co-expression of
the wild-type of N-terminal part of ezrin fused to
VP16 transcription activation region as a prey, and
the C-terminal part of NHERF-1 fused to GAL4
DNA binding domain as a bait significantly in-
creased the luciferase activity, indicating that the
N-terminal part of ezrin can bind to the C-terminal
part of NHERF-1 (Fig. 4). S249D mutant of the N-
terminal part of ezrin as the prey clearly inhibited
the luciferase activity, indicating that S249D mutant
inhibited the interaction with NHERF-1. In contrast,
S149D mutant was not inhibited to bind to NHERF-
1. Our data suggest that phosphorylation of ezrin
S249 may inhibit the interaction between ezrin and
NHERF-1, resulting in decreased apical localization
of NaPi-IIa and P transport activity.
It is unknown how the modification of S249 affects
the interaction with NHERF-1. S249 is highly con-
served within the ERM family and is located in the
β5C strand in the FERM subdomain C of ezrin,
which is important for binding to NHERF-1 (20).
NHERF-1 binds to the groove between two β sheets
in the FERM subdomain C, the four-stranded sheet
β1C-β4C (aa 203-240) and the three-stranded sheet
β5C-β7C (aa 243-270). Phe240, Ile257, Pro265, and
Pro259 form a hydrophobic pocket which accommo-
dates Trp348 from the NHERF-1 peptide (20). Sub-
stitution of aspartic acid for serine in the FERM
subdomain C may affect the hydrophobicity of the
pocket or be involved in steric hindrance. Further
investigation of structural basis analysis is required.
In summary, we investigated the role of serine
249 of ezrin in the formation of NaPi-IIa complex
in the plasma membrane of renal proximal tubular
cells. As illustrated in Fig. 5A, NaPi-IIa can be lo-
calized in the apical plasma membrane by tethering
to cytoskeletal actin via formation of the complex
with NHERF-1 and ezrin. Overexpression of ezrin-
DN can interfere the linking activity of endogenous
ezrin between NHERF-1 and actin as we described
above (Fig. 5B). This dominant negative effect of
ezrin can affect the apical localization of NaPi-IIa,
and somehow internalize NaPi-IIa from apical mem-
brane by stimulating endocytosis as previously re-
ported (9, 10, 16). Phosphomimetic mutant of ezrin-
DN (ezrin-DN/S249D) did not have dominant nega-
tive function (Fig. 2 and Fig. 3A), suggesting that
ezrin-DN/S249D does not interfere the linking ac-
tivity of endogenous ezrin as shown in Fig. 5C.
Our previous study proposed a hypothesis that
phosphorylation of ezrin can regulate the apical lo-
calization of NaPi-IIa in renal proximal tubular cells
(10). The findings of the present study support
this hypothesis because modification of the FERM
subdomain C of ezrin was shown to regulate the
Fig. 4 Effect of phosphomimetic mutants of ezrin on the in-
teraction with NHERF-1 C-terminal domain by mammalian two-
hybrid assay. Indicated bait (NHERF-1) and prey (ezrin or its
mutant) vectors, luciferase reporter vector, and β -galactosidase
expression vector were co-transfected into COS-7 cells. Lu-
ciferase activity and β -galactosidase activity were measured.
Luciferase activity was normalized against β -galactosidase activ-
ity, and luciferase activity of NHERF-1/mock was set to 1. Data
are meanSEM (n=6-8). *p0.05 vs. NHERF-1/mock, #p
0.05 vs. NHERF-1/Ezrin.
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interaction with NHERF-1, apical localization of
NaPi-IIa, and P transport activity, at least in vitro .
Therefore, those data suggest that phosphorylation
of S249 of ezrin by PKA activated in response to
hormonal stimulation or others could inhibit the
tethering the NaPi-IIa complex to actin by inhibit-
ing interaction with NHERF-1, decrease the amount
of NaPi-IIa in the apical membrane by endocytosis
(Fig. 5D), and eventually decrease the P reabsorp-
tion activity in vivo . However, we cannot clearly as-
sess the importance of phosphorylated modification
of ezrin in hormonal regulation of NaPi-IIa in vivo
at this time. Recently, Nagai et al. reported that the
cAMP/PKA pathway mainly down-regulates NaPi-
IIa in response to PTH in vivo (21). Our data agree
with the importance of the cAMP/PKA pathway in
the regulation of NaPi-IIa activity. The regulation
of NaPi-IIa via the modification of ezrin are impor-
tant to understand the molecular mechanisms for
the regulation of phosphate homeostasis.
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